Xovoltib 50 Mg (Afatinib Dimaleate)
Xovoltib 50 mg contains afatinib dimaleate, a second-generation, irreversible tyrosine kinase inhibitor targeting EGFR and HER2 receptors. Designed for patients with advanced or metastatic non‑small cell lung cancer (NSCLC) driven by activating EGFR mutations, this 50 mg dose offers intensified exposure for individuals who require potent systemic therapy beyond lower dose options.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
✅ Key Benefits
-
High-dose irreversible inhibition of EGFR and HER2 signaling for enhanced tumor control
-
Ideal for patients requiring dose escalation due to mutation profile or suboptimal response at lower doses
-
Oral tablet enables convenient once-daily dosing
-
May penetrate the central nervous system—possibly beneficial for brain metastases in EGFR-positive patients
-
Enables precision dose tailoring according to patient tolerance and clinical needs
🎯 How to Use
-
Take one 50 mg tablet orally once daily, at the same time each day, with or without food
-
Continue therapy until disease progression or intolerable side effects occur
-
Dose reductions to 40, 30, or 20 mg may be necessary to manage side effects
-
Close clinical monitoring is essential—track liver function, skin, GI symptoms, and overall tolerance
⚠️ Precautions
-
Prescription-only; confirm EGFR or HER2 mutation status via molecular testing prior to use
-
Elevated risk of side effects such as diarrhea, skin rash, and mucositis at higher dose
-
Periodic liver function testing recommended—dose adjustments may be required
-
Monitor for cardiac effects (QT prolongation) or pulmonary symptoms—especially in high-risk patients
-
Not safe during pregnancy—effective contraception advised during and after therapy
🤕 Possible Side Effects
Common:
-
Significant diarrhea, acneiform rash, mouth ulcers, skin dryness, nail changes, fatigue
Less Common:
-
Elevated liver enzymes, nausea, appetite loss, mild weight changes, headache
Rare but Serious:
-
Severe hepatotoxicity, dehydration, pneumonitis/interstitial lung disease, QT prolongation, bradycardia
-
Stop treatment and seek medical care if symptoms such as chest pain, breathlessness, yellowing of skin/eyes, severe abdominal pain, or fainting occur
🎁 Special Offers
-
💰 Up to 50% OFF sitewide
-
🚚 Free shipping on orders over ₹1999 (or equivalent)
-
📦 Discreet, secure packaging and confidential checkout
❓ Frequently Asked Questions (FAQs)
Q. Who should take Xovoltib 50 mg?
Patients with advanced EGFR-mutated NSCLC requiring high-dose therapy due to resistance or non-response to standard lower doses.
Q. Is dosing flexible if I can’t tolerate 50 mg?
Yes. Dose can be reduced stepwise to 40 mg, 30 mg, or even 20 mg, depending on tolerability and clinical guidance.
Q. Should I take it with food?
You may take Xovoltib 50 mg with or without food. Consistency in timing each day helps maintain steady drug exposure.
Q. What if I miss a dose?
Take it as soon as you remember—unless it’s close to the next dose. Never take two doses in a single day. Consult your healthcare provider if multiple doses are missed.
Q. How are side effects managed at higher doses?
Management may include dose reduction or temporary interruption, along with supportive care—like hydration for diarrhea or topical treatments for rash. Monitoring labs helps detect serious effects early.
| Unit | 28 Tablets, 56 Tablets, 84 Tablets |
|---|










Reviews
There are no reviews yet.